Caroline S Fox

Author PubWeight™ 722.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 2011 31.98
2 Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 2012 30.79
3 Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation 2010 30.07
4 Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation 2013 28.02
5 Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010 23.08
6 Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010 20.01
7 New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010 17.89
8 Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010 16.96
9 Metabolite profiles and the risk of developing diabetes. Nat Med 2011 12.22
10 Genome-wide association study of blood pressure and hypertension. Nat Genet 2009 11.54
11 Variants in MTNR1B influence fasting glucose levels. Nat Genet 2008 10.85
12 The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol 2007 9.90
13 Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 2008 9.68
14 Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 2007 8.59
15 Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 2010 7.94
16 Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 2010 6.66
17 Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation 2014 6.55
18 Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation 2007 6.34
19 Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007 6.29
20 Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 2012 6.24
21 Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 2013 6.13
22 Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008 5.95
23 Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008 5.89
24 New loci associated with kidney function and chronic kidney disease. Nat Genet 2010 5.58
25 Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med 2014 5.47
26 Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006 5.33
27 Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007 5.10
28 The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports. BMC Med Genet 2007 5.02
29 Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA 2013 4.81
30 Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 2009 4.78
31 A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 2012 4.37
32 Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet 2009 4.28
33 Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005 4.08
34 Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes 2010 4.07
35 Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 2011 3.92
36 Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 2010 3.60
37 Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 2009 3.54
38 Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2006 3.48
39 Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. J Clin Endocrinol Metab 2010 3.39
40 Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2008 3.33
41 On the replication of genetic associations: timing can be everything! Am J Hum Genet 2008 3.32
42 Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet 2013 3.25
43 Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet 2010 3.24
44 Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 2011 3.23
45 Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009 3.23
46 Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 2012 3.21
47 Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet 2011 3.18
48 NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium. PLoS Genet 2009 3.18
49 Visceral fat is associated with lower brain volume in healthy middle-aged adults. Ann Neurol 2010 3.05
50 Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet 2012 3.04
51 Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes. BMC Med Genet 2007 2.93
52 Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet 2013 2.83
53 Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care 2009 2.80
54 FTO genotype is associated with phenotypic variability of body mass index. Nature 2012 2.77
55 Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet 2010 2.76
56 Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet 2011 2.73
57 Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 2008 2.70
58 CUBN is a gene locus for albuminuria. J Am Soc Nephrol 2011 2.70
59 Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 2009 2.70
60 Statin use and sepsis events [corrected] in patients with chronic kidney disease. JAMA 2007 2.69
61 Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol 2008 2.64
62 Long-term trends in myocardial infarction incidence and case fatality in the National Heart, Lung, and Blood Institute's Framingham Heart study. Circulation 2009 2.63
63 A 100K genome-wide association scan for diabetes and related traits in the Framingham Heart Study: replication and integration with other genome-wide datasets. Diabetes 2007 2.60
64 Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet 2012 2.53
65 Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation 2012 2.51
66 Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes 2010 2.44
67 Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring) 2010 2.42
68 Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults. Diabetes Care 2010 2.38
69 Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab 2010 2.37
70 The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts. PLoS Genet 2007 2.35
71 Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med 2006 2.28
72 Defining normal distributions of coronary artery calcium in women and men (from the Framingham Heart Study). Am J Cardiol 2008 2.26
73 Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes 2011 2.21
74 Analyze multivariate phenotypes in genetic association studies by combining univariate association tests. Genet Epidemiol 2010 2.19
75 Visceral and subcutaneous fat quality and cardiometabolic risk. JACC Cardiovasc Imaging 2013 2.19
76 High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2004 2.17
77 2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest 2013 2.15
78 Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet 2010 2.15
79 Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension 2011 2.13
80 Uromodulin levels associate with a common UMOD variant and risk for incident CKD. J Am Soc Nephrol 2009 2.10
81 Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005 2.09
82 Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care 2010 2.06
83 Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab 2008 2.03
84 Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study. BMC Med Genet 2007 2.00
85 Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol 2013 1.96
86 Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation 2011 1.96
87 Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality. Arterioscler Thromb Vasc Biol 2010 1.95
88 Increasing trends in incidence of overweight and obesity over 5 decades. Am J Med 2007 1.95
89 Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque. Nat Genet 2011 1.92
90 Genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six Loci influencing serum magnesium levels. PLoS Genet 2010 1.91
91 Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population. Am J Kidney Dis 2011 1.88
92 Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart Study. Metabolism 2005 1.88
93 Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis 2008 1.82
94 Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes. Arch Intern Med 2007 1.81
95 A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study. Circ Cardiovasc Genet 2012 1.81
96 Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes 2008 1.80
97 Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation 2009 1.77
98 Pericardial adipose tissue, atherosclerosis, and cardiovascular disease risk factors: the Jackson heart study. Diabetes Care 2010 1.77
99 Ectopic fat depots and cardiovascular disease. Circulation 2011 1.77
100 Parental occurrence of premature cardiovascular disease predicts increased coronary artery and abdominal aortic calcification in the Framingham Offspring and Third Generation cohorts. Circulation 2007 1.75
101 Relations of insulin sensitivity to longitudinal blood pressure tracking: variations with baseline age, body mass index, and blood pressure. Circulation 2005 1.75
102 Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol 2008 1.74
103 Volumetric measurement of pericardial adipose tissue from contrast-enhanced coronary computed tomography angiography: a reproducibility study. J Cardiovasc Comput Tomogr 2008 1.73
104 A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One 2012 1.72
105 TCF7L2 variants associate with CKD progression and renal function in population-based cohorts. J Am Soc Nephrol 2008 1.71
106 Biomarkers of cardiovascular stress and incident chronic kidney disease. Clin Chem 2013 1.71
107 The MYH9/APOL1 region and chronic kidney disease in European-Americans. Hum Mol Genet 2011 1.71
108 Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol 2010 1.70
109 Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease. Circulation 2008 1.68
110 Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet 2012 1.68
111 Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD. PLoS Genet 2011 1.68
112 The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment. Am J Kidney Dis 2007 1.67
113 Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study. Diabetes Care 2011 1.66
114 Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals. Am J Cardiol 2011 1.65
115 Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. Circulation 2007 1.65
116 Multiple loci are associated with white blood cell phenotypes. PLoS Genet 2011 1.65
117 Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study. J Gastroenterol Hepatol 2008 1.62
118 Genetics of the Framingham Heart Study population. Adv Genet 2008 1.62
119 Patterns of abdominal fat distribution: the Framingham Heart Study. Diabetes Care 2008 1.62
120 Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care 2007 1.61
121 Genetic association for renal traits among participants of African ancestry reveals new loci for renal function. PLoS Genet 2011 1.60
122 Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study. Diabetes Care 2007 1.60
123 Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. Atherosclerosis 2010 1.60
124 Simple area-based measurement for multidetector computed tomography to predict left ventricular size. Eur Radiol 2010 1.59
125 Genome-wide association with diabetes-related traits in the Framingham Heart Study. BMC Med Genet 2007 1.59
126 Variants in the CNR1 and the FAAH genes and adiposity traits in the community. Obesity (Silver Spring) 2009 1.58
127 Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention. JACC Cardiovasc Interv 2011 1.57
128 Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study). Am J Cardiol 2008 1.56
129 Common variants in the calcium-sensing receptor gene are associated with total serum calcium levels. Hum Mol Genet 2010 1.53
130 Overlap between common genetic polymorphisms underpinning kidney traits and cardiovascular disease phenotypes: the CKDGen consortium. Am J Kidney Dis 2013 1.52
131 Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Metab 2011 1.50
132 Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care 2014 1.47
133 Axial area and anteroposterior diameter as estimates of left atrial size using computed tomography of the chest: comparison with 3-dimensional volume. J Cardiovasc Comput Tomogr 2009 1.47
134 Inflammation, kidney function and albuminuria in the Framingham Offspring cohort. Nephrol Dial Transplant 2010 1.46
135 Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes 2006 1.46
136 A combined epidemiologic and metabolomic approach improves CKD prediction. J Am Soc Nephrol 2013 1.42
137 A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study. BMC Med Genet 2007 1.42
138 Arterial stiffness in mild-to-moderate CKD. J Am Soc Nephrol 2009 1.41
139 Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: the Jackson Heart Study. Atherosclerosis 2012 1.40
140 Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med 2008 1.37
141 Reference values for normal pulmonary artery dimensions by noncontrast cardiac computed tomography: the Framingham Heart Study. Circ Cardiovasc Imaging 2011 1.34
142 Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Circulation 2015 1.33
143 Low hemoglobin A1c and risk of all-cause mortality among US adults without diabetes. Circ Cardiovasc Qual Outcomes 2010 1.33
144 Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation 2014 1.32
145 Association of lifestyle factors with abdominal subcutaneous and visceral adiposity: the Framingham Heart Study. Diabetes Care 2008 1.31
146 Discovery and fine mapping of serum protein loci through transethnic meta-analysis. Am J Hum Genet 2012 1.29
147 The PLIN4 variant rs8887 modulates obesity related phenotypes in humans through creation of a novel miR-522 seed site. PLoS One 2011 1.28
148 Prevalence, distribution, and risk factor correlates of high pericardial and intrathoracic fat depots in the Framingham heart study. Circ Cardiovasc Imaging 2010 1.25
149 Genome-wide association of body fat distribution in African ancestry populations suggests new loci. PLoS Genet 2013 1.24
150 Genome-wide analysis of BMI in adolescents and young adults reveals additional insight into the effects of genetic loci over the life course. Hum Mol Genet 2013 1.23
151 Heritability of the ankle-brachial index: the Framingham Offspring study. Am J Epidemiol 2006 1.23
152 Fatty liver, abdominal visceral fat, and cardiometabolic risk factors: the Jackson Heart Study. Arterioscler Thromb Vasc Biol 2011 1.21
153 Common genetic variants associate with serum phosphorus concentration. J Am Soc Nephrol 2010 1.20
154 Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation. Am J Cardiol 2012 1.17
155 Visceral and subcutaneous adiposity and brachial artery vasodilator function. Obesity (Silver Spring) 2009 1.17
156 Age-related associations of hypertension and diabetes mellitus with chronic kidney disease. BMC Nephrol 2009 1.16
157 Cross-sectional associations between abdominal and thoracic adipose tissue compartments and adiponectin and resistin in the Framingham Heart Study. Diabetes Care 2009 1.15
158 Haplotype structure of the ENPP1 Gene and Nominal Association of the K121Q missense single nucleotide polymorphism with glycemic traits in the Framingham Heart Study. Diabetes 2008 1.15
159 Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study. Gastroenterology 2008 1.15
160 Whole- and refined-grain intakes are differentially associated with abdominal visceral and subcutaneous adiposity in healthy adults: the Framingham Heart Study. Am J Clin Nutr 2010 1.14
161 Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease. Nephrol Dial Transplant 2011 1.14
162 Pericardial fat volume correlates with inflammatory markers: the Framingham Heart Study. Obesity (Silver Spring) 2009 1.14
163 Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. Hum Mol Genet 2012 1.14
164 Predictors of incident albuminuria in the Framingham Offspring cohort. Am J Kidney Dis 2010 1.13
165 Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study. Circ Cardiovasc Imaging 2010 1.13
166 Life-course socioeconomic position and type 2 diabetes mellitus: The Framingham Offspring Study. Am J Epidemiol 2011 1.13
167 Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele. Hum Mol Genet 2011 1.13
168 Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis. Diabetes 2011 1.13
169 A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genet 2013 1.12
170 The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study. BMC Nephrol 2010 1.11
171 Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care 2015 1.10
172 Fat quality and incident cardiovascular disease, all-cause mortality, and cancer mortality. J Clin Endocrinol Metab 2015 1.10
173 Association of APOE genotype with carotid atherosclerosis in men and women: the Framingham Heart Study. J Lipid Res 2004 1.10
174 Differential estimation of CKD using creatinine- versus cystatin C-based estimating equations by category of body mass index. Am J Kidney Dis 2009 1.10
175 Sequence kernel association test for survival traits. Genet Epidemiol 2014 1.09
176 Analysis of a urinary biomarker panel for incident kidney disease and clinical outcomes. J Am Soc Nephrol 2013 1.08
177 Neck circumference and the development of cardiovascular disease risk factors in the Framingham Heart Study. Diabetes Care 2013 1.08
178 Genome-wide linkage analysis to age at natural menopause in a community-based sample: the Framingham Heart Study. Fertil Steril 2005 1.08
179 Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes. Diabetes 2007 1.08
180 Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus: A Scientific Statement From the American Heart Association. Circulation 2015 1.08
181 Elevated galectin-3 precedes the development of CKD. J Am Soc Nephrol 2013 1.06
182 Genetic variation associated with circulating monocyte count in the eMERGE Network. Hum Mol Genet 2013 1.05
183 Serum gamma-glutamyl transferase and risk of heart failure in the community. Arterioscler Thromb Vasc Biol 2010 1.05
184 Blood pressure and the risk of developing diabetes in african americans and whites: ARIC, CARDIA, and the framingham heart study. Diabetes Care 2011 1.05
185 A comparison of strategies for analyzing dichotomous outcomes in genome-wide association studies with general pedigrees. Genet Epidemiol 2011 1.04
186 Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study. Diabetes 2008 1.04
187 Burden and rates of treatment and control of cardiovascular disease risk factors in obesity: the Framingham Heart Study. Diabetes Care 2008 1.03
188 Prevalence and distribution of abdominal aortic calcium by gender and age group in a community-based cohort (from the Framingham Heart Study). Am J Cardiol 2012 1.03
189 Resequencing and clinical associations of the 9p21.3 region: a comprehensive investigation in the Framingham heart study. Circulation 2013 1.03
190 Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) study. Am J Nephrol 2011 1.03
191 Relations of measures of endothelial function and kidney disease: the Framingham Heart Study. Am J Kidney Dis 2008 1.03
192 Intramuscular fat and associations with metabolic risk factors in the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2013 1.02
193 Yogurt consumption is associated with better diet quality and metabolic profile in American men and women. Nutr Res 2012 1.02
194 Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations. PLoS Genet 2013 1.02
195 Dietary patterns, abdominal visceral adipose tissue, and cardiometabolic risk factors in African Americans: the Jackson heart study. Obesity (Silver Spring) 2013 1.01
196 Prevalence of reduced estimated glomerular filtration rate among the oldest old from 1988-1994 through 2005-2010. JAMA 2013 1.01
197 Sex and age specific effects of chromosomal regions linked to body mass index in the Framingham Study. BMC Genet 2006 1.00
198 Association of visceral and subcutaneous adiposity with kidney function. Clin J Am Soc Nephrol 2008 1.00
199 Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart Study. Am J Hypertens 2005 1.00
200 The type 2 deiodinase (DIO2) A/G polymorphism is not associated with glycemic traits: the Framingham Heart Study. Thyroid 2007 0.98
201 Perivascular adipose tissue and vascular disease. Clin Lipidol 2011 0.98
202 Genome-wide association studies of chronic kidney disease: what have we learned? Nat Rev Nephrol 2011 0.98
203 Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study. Obesity (Silver Spring) 2010 0.97
204 Eligibility of individuals with subclinical coronary artery calcium and intermediate coronary heart disease risk for reclassification (from the Framingham Heart Study). Am J Cardiol 2009 0.97
205 Diet quality, physical activity, smoking status, and weight fluctuation are associated with weight change in women and men. J Nutr 2010 0.97
206 Association of female reproductive factors with body composition: the Framingham Heart Study. J Clin Endocrinol Metab 2012 0.97
207 Prevalence, distribution, and risk factor correlates of high thoracic periaortic fat in the Framingham Heart Study. J Am Heart Assoc 2012 0.96
208 Consent for genetic research in the Framingham Heart Study. Am J Med Genet A 2010 0.96
209 Calcium intake is not associated with increased coronary artery calcification: the Framingham Study. Am J Clin Nutr 2012 0.96
210 Indexes of kidney function and coronary artery and abdominal aortic calcium (from the Framingham Offspring Study). Am J Cardiol 2008 0.96
211 Performance of a genetic risk score for CKD stage 3 in the general population. Am J Kidney Dis 2011 0.96
212 Predicting stroke through genetic risk functions: the CHARGE Risk Score Project. Stroke 2014 0.96
213 Distribution, determinants, and normal reference values of thoracic and abdominal aortic diameters by computed tomography (from the Framingham Heart Study). Am J Cardiol 2013 0.96
214 Development and reproducibility of a computed tomography-based measurement of renal sinus fat. BMC Nephrol 2011 0.95
215 BMI modifies associations of IL-6 genotypes with insulin resistance: the Framingham Study. Obesity (Silver Spring) 2006 0.95
216 No association between hemoglobin A1c and in-hospital mortality in patients with diabetes and acute myocardial infarction. Am Heart J 2011 0.95
217 Validated SNPs for eGFR and their associations with albuminuria. Hum Mol Genet 2012 0.95
218 Periaortic adipose tissue and aortic dimensions in the Framingham Heart Study. J Am Heart Assoc 2012 0.95
219 Addition of inflammatory biomarkers did not improve diabetes prediction in the community: the framingham heart study. J Am Heart Assoc 2012 0.95
220 Implications of rising prediabetes prevalence. Diabetes Care 2013 0.94
221 Pericardial fat and echocardiographic measures of cardiac abnormalities: the Jackson Heart Study. Diabetes Care 2011 0.94
222 Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study). Am J Cardiol 2008 0.94
223 Basic concepts and potential applications of genetics and genomics for cardiovascular and stroke clinicians: a scientific statement from the American Heart Association. Circ Cardiovasc Genet 2015 0.93
224 Chronic kidney disease defined by cystatin C predicts mobility disability and changes in gait speed: the Framingham Offspring Study. J Gerontol A Biol Sci Med Sci 2013 0.93
225 A risk score for chronic kidney disease in the general population. Am J Med 2012 0.93
226 Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial. Heart 2011 0.93
227 Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals. Diabetes Care 2008 0.92
228 Protein biomarkers of new-onset cardiovascular disease: prospective study from the systems approach to biomarker research in cardiovascular disease initiative. Arterioscler Thromb Vasc Biol 2014 0.92
229 Metabolic abnormalities are present in adults with elevated serum cystatin C. Kidney Int 2009 0.92
230 Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study. J Lipid Res 2006 0.91
231 Clinical correlates of circulating visfatin levels in a community-based sample. Diabetes Care 2007 0.91
232 Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2012 0.91
233 Association of pericardial fat and coronary high-risk lesions as determined by cardiac CT. Atherosclerosis 2012 0.90
234 PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample. Obesity (Silver Spring) 2006 0.90
235 Neck circumference, carotid wall intima-media thickness, and incident stroke. Diabetes Care 2013 0.90
236 Relations of long-term and contemporary lipid levels and lipid genetic risk scores with coronary artery calcium in the framingham heart study. J Am Coll Cardiol 2012 0.89
237 Association of estimated glomerular filtration rate and urinary uromodulin concentrations with rare variants identified by UMOD gene region sequencing. PLoS One 2012 0.89
238 Differential associations of abdominal visceral, subcutaneous adipose tissue with cardiometabolic risk factors between African and European Americans. Obesity (Silver Spring) 2014 0.89
239 Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals. Circulation 2007 0.88
240 Low ankle-brachial index and the development of rapid estimated GFR decline and CKD. Am J Kidney Dis 2012 0.88
241 Early-adulthood cardiovascular disease risk factor profiles among individuals with and without diabetes in the Framingham Heart Study. Diabetes Care 2013 0.88
242 Depressive symptoms are associated with visceral adiposity in a community-based sample of middle-aged women and men. Obesity (Silver Spring) 2013 0.87
243 Genetics of chronic kidney disease. Nephron Clin Pract 2010 0.87
244 Association of parental obesity with concentrations of select systemic biomarkers in nonobese offspring: the Framingham Heart Study. Diabetes 2008 0.87
245 Breastfeeding in infancy and adult cardiovascular disease risk factors. Am J Med 2009 0.87
246 Importance of different types of prior knowledge in selecting genome-wide findings for follow-up. Genet Epidemiol 2013 0.87
247 SNP prioritization using a Bayesian probability of association. Genet Epidemiol 2012 0.86
248 Influence of pericoronary adipose tissue on local coronary atherosclerosis as assessed by a novel MDCT volumetric method. Atherosclerosis 2011 0.86
249 The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humans. Metabolism 2009 0.86
250 Using family-based imputation in genome-wide association studies with large complex pedigrees: the Framingham Heart Study. PLoS One 2012 0.86
251 No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels. Diabetes 2012 0.86
252 Variation in estrogen-related genes associated with cardiovascular phenotypes and circulating estradiol, testosterone, and dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab 2008 0.85
253 Thoracic periaortic and visceral adipose tissue and their cross-sectional associations with measures of vascular function. Obesity (Silver Spring) 2013 0.84
254 Lifestyle factors and indices of kidney function in the Framingham Heart Study. Am J Nephrol 2015 0.84
255 Pericardial fat is associated with atrial conduction: the Framingham Heart Study. J Am Heart Assoc 2014 0.84
256 Correlation of renin angiotensin and aldosterone system activity with subcutaneous and visceral adiposity: the framingham heart study. BMC Endocr Disord 2012 0.84
257 A three-stage approach for genome-wide association studies with family data for quantitative traits. BMC Genet 2010 0.84
258 Sugar-sweetened beverages and prevalence of the metabolically abnormal phenotype in the Framingham Heart Study. Obesity (Silver Spring) 2014 0.84
259 Gene-centric meta-analyses for central adiposity traits in up to 57 412 individuals of European descent confirm known loci and reveal several novel associations. Hum Mol Genet 2013 0.84
260 Association between parental history of diabetes and type 2 diabetes genetic risk scores in the PPP-Botnia and Framingham Offspring Studies. Diabetes Res Clin Pract 2011 0.84
261 SORCS1 contributes to the development of renal disease in rats and humans. Physiol Genomics 2013 0.83
262 Copy number polymorphisms near SLC2A9 are associated with serum uric acid concentrations. BMC Genet 2014 0.83
263 Association of colony-forming units with coronary artery and abdominal aortic calcification. Circulation 2010 0.83
264 Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies. BMC Med Genet 2008 0.83
265 Association between well-characterized lipoprotein-related genetic variants and carotid intimal medial thickness and stenosis: The Framingham Heart Study. Atherosclerosis 2006 0.83
266 Insulin resistance and atrial fibrillation (from the Framingham Heart Study). Am J Cardiol 2011 0.83
267 Metabolic characterization of adults with binge eating in the general population: the Framingham Heart Study. Obesity (Silver Spring) 2014 0.83
268 Genome-wide association analysis of plasma B-type natriuretic peptide in blacks: the Jackson Heart Study. Circ Cardiovasc Genet 2015 0.83
269 Risk of type 2 diabetes and cumulative excess weight exposure in the Framingham Offspring Study. J Diabetes Complications 2013 0.82
270 Lack of association between the type 2 deiodinase A/G polymorphism and hypertensive traits: the Framingham Heart Study. Hypertension 2008 0.82
271 Common variants in Mendelian kidney disease genes and their association with renal function. J Am Soc Nephrol 2013 0.82
272 Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study. Diabetol Metab Syndr 2012 0.81
273 Fasting glucose, obesity, and coronary artery calcification in community-based people without diabetes. Diabetes Care 2012 0.81
274 Meta-analysis of genome-wide linkage scans for renal function traits. Nephrol Dial Transplant 2011 0.81
275 Heritability of serum gamma-glutamyltransferase level: genetic analysis from the Framingham Offspring Study. Liver Int 2009 0.81
276 Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering. Metab Syndr Relat Disord 2014 0.81
277 Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association. Circulation 2015 0.81
278 Association of chronic kidney disease with adverse outcomes - Authors' reply. Lancet 2013 0.80
279 Enhancing Literacy in Cardiovascular Genetics: A Scientific Statement From the American Heart Association. Circ Cardiovasc Genet 2016 0.80
280 Functional validation of GWAS gene candidates for abnormal liver function during zebrafish liver development. Dis Model Mech 2013 0.79
281 Heritability and genome-wide association analysis of renal sinus fat accumulation in the Framingham Heart Study. BMC Med Genet 2011 0.79
282 Phylloquinone and vitamin D status: associations with incident chronic kidney disease in the Framingham Offspring cohort. Am J Nephrol 2012 0.78
283 Type 2 diabetes risk in persons with dysglycemia: the Framingham Offspring Study. Diabetes Res Clin Pract 2011 0.78
284 Subclinical and clinical correlates of left ventricular wall motion abnormalities in the community. Am J Cardiol 2011 0.78
285 The association of a single-nucleotide polymorphism in CUBN and the risk of albuminuria and cardiovascular disease. Nephrol Dial Transplant 2013 0.77
286 Metabolic factors and genetic risk mediate familial type 2 diabetes risk in the Framingham Heart Study. Diabetologia 2015 0.77
287 Relation of vascular growth factors with CT-derived measures of body fat distribution: the Framingham Heart Study. J Clin Endocrinol Metab 2011 0.77
288 Variants at the endocannabinoid receptor CB1 gene (CNR1) and insulin sensitivity, type 2 diabetes, and coronary heart disease. Obesity (Silver Spring) 2011 0.77
289 Development and reproducibility of a computed tomography-based measurement for upper body subcutaneous neck fat. J Am Heart Assoc 2014 0.76
290 Lack of interaction of beta-cell-function-associated variants with hypertension on change in fasting glucose and diabetes risk: the Framingham Offspring Study. J Hypertens 2013 0.75
291 Correction: The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study. PLoS Genet 2016 0.75
292 Distribution of abdominal aortic calcium by computed tomography: impact of analysis method on quantitative calcium score. Acad Radiol 2013 0.75
293 Sequence variation in TMEM18 in association with body mass index: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study. Circ Cardiovasc Genet 2014 0.75
294 The fourth dimension: associations of change in albuminuria over time. J Am Soc Nephrol 2011 0.75
295 Weighty matters: balancing weight gain with cardiovascular risk among patients with type 1 diabetes mellitus on intensive insulin therapy. Circulation 2012 0.75
296 Correction: Genome-wide physical activity interactions in adiposity - A meta-analysis of 200,452 adults. PLoS Genet 2017 0.75
297 Editor's note. Circulation 2013 0.75
298 Corrigendum: 1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function. Sci Rep 2017 0.75
299 Residential Proximity to Major Roadways, Fine Particulate Matter, and Hepatic Steatosis: The Framingham Heart Study. Am J Epidemiol 2017 0.75